Deutsche Bank and its Swedish biotech client, Perbio Science, have accepted a Skr5.3bn (€577m) offer from Fisher Scientific International, the US laboratory equipment maker.
The target recommended the Skr142.5-a-share cash bid to shareholders. It represented a 28% premium to the volume-weighted average price of Perbio's shares over the past 60 trading days and a 14% premium to their previous close.